Li Lin

机构：Philips (Finland), Philips (China) · ORCID：0000-0003-3861-8220

发表论文 55 篇 · 总被引 527 次 · h-index 14

代表论文

Sacubitril/valsartan attenuated myocardial inflammation, fibrosis, apoptosis and promoted autophagy in doxorubicin-induced cardiotoxicity mice via regulating the AMPKα–mTORC1 signaling pathway (2024 · Molecular and Cellular Biochemistry · 被引 21)
Brief Report: Ivonescimab Combined With Etoposide Plus Carboplatin as First-Line Treatment for Extensive-Stage SCLC: Results of a Phase 1b Clinical Trial (2024 · Journal of Thoracic Oncology · 被引 19)
Impact of bronchoscopic thermal vapor ablation on lung volume reduction in patients with emphysema: a meta-analysis (2023 · BMC Pulmonary Medicine · 被引 13)
Therapeutic outcome of dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials (2023 · African Health Sciences · 被引 12)
The NEDD8 activating enzyme inhibitor MLN4924 mitigates doxorubicin-induced cardiotoxicity in mice (2024 · Free Radical Biology and Medicine · 被引 11)
Prognostic value of neutrophil-to-lymphocyte ratio in patients with non–muscle-invasive bladder cancer with intravesical Bacillus Calmette–Guérin immunotherapy: a systematic review and meta-analysis (2024 · Frontiers in Immunology · 被引 6)